Chemoprevention of lung squamous cell carcinoma by ginseng

Cancer Prevention Research

Volumn 6, Issue 6, 2013, Pages 530-539

  Pan, Jing ^a   Zhang, Qi ^a   Li, Kezhen ^a   Liu, Qian ^a   Wang, Yian ^b   You, Ming ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE F 1; GINSENOSIDE F 2; GINSENOSIDE F 3; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RB 3; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 2; GINSENOSIDE RG 3; GINSENOSIDE RH 1; GINSENOSIDE RH 2; GINSENOSIDE X; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COMPARATIVE STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME PHOSPHORYLATION; GINSENG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPERPLASIA; LUNG CARCINOGENESIS; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; FEMALE; GINSENOSIDES; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MICE; NF-KAPPA B; PANAX; PHYTOTHERAPY; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

EID: 84878883346     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0366     Document Type: Article

References (38)

1. Yun TK. Panax ginseng - a non-organ-specific cancer preventive? Lancet Oncol 2001;2:49-55.
2. Deyama T, Nishibe S, Nakazawa Y. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacol Sin 2001;22:1057-70.
3. Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin 2008;29:1109-18.
4. Shimizu Y, Suzuki T, Oda K, Morishita S. [Pharmacological studies of Reiousan, a drug containing bezoar and ginseng-effects on the blood rheology]. Yakugaku Zasshi 1999;119:731-41.
5. Tong CN, Matsuda H, Kubo M. [Pharmacological study on Panax ginseng C. A. Meyer. XV. Effects of 70% methanolic extract from red and white ginseng on the antitumor activity of mitomycin C]. Yakugaku Zasshi 1992;112:856-65.
6. Li JC, Zheng QJ, Jin CH, Ma RM. [Circadian changes in the pharmacological effects of red ginseng saponins in mice]. Zhongguo Yao Li Xue Bao 1988;9:22-6.
7. Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004;9:259-74. (Pubitemid 39299200)
8. Yun TK, Choi SY. A case-control study of ginseng intake and cancer. Int J Epidemiol 1990;19:871-6.
9. Yun TK, Choi SY. Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev 1995;4:401-8.
10. Yun TK, Choi SY. Non-organ specific cancer prevention of ginseng: a prospective study in Korea. Int J Epidemiol 1998;27:359-64.
11. Dougherty U, Mustafi R, Wang Y, Musch MW, Wang CZ, Konda VJ, et al. American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: role of EGFR. BMC Complement Altern Med 2011;11:111.
12. Wu XG, Zhu DH. Influence of ginseng upon the development of liver cancer induced by diethylnitrosamine in rats. J Tongji Med Univ 1990;10:141-5.
13. Watanabe T, Watanabe M, Watanabe Y, Hotta C. Effects of oral administration of Pfaffia paniculata (Brazilian ginseng) on incidence of spontaneous leukemia in AKR/J mice. Cancer Detect Prev 2000;24:173-8. (Pubitemid 30427705)
14. Konoshima T, Takasaki M, Ichiishi E, Murakami T, Tokuda H, Nishino H, et al. Cancer chemopreventive activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis. Cancer Lett 1999;147:11-6.
15. Nishino H, Tokuda H, Ii T, Takemura M, Kuchide M, Kanazawa M, et al. Cancer chemoprevention by ginseng in mouse liver and other organs. J Korean Med Sci 2001;16:S66-9.
16. Panwar M, Samarth R, Kumar M, Yoon WJ, Kumar A. Inhibition of benzo(a)pyrene induced lung adenoma by panax ginseng extract, EFLA400, in Swiss albino mice. Biol Pharm Bull 2005;28:2063-7. (Pubitemid 41634253)
17. Yun TK, Yun YS, Han IW. Anticarcinogenic effect of long-term oral administration of red ginseng on newborn mice exposed to various chemical carcinogens. Cancer Detect Prev 1983;6:515-25.
18. Yan Y, Wang Y, Tan Q, Hara Y, Yun TK, Lubet RA, et al. Efficacy of polyphenon E, red ginseng, and rapamycin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice. Neoplasia 2006;8:52-8.
19. Wang Y, Zhang Z, Garbow JR, Rowland DJ, Lubet RA, Sit D, et al. Chemoprevention of lung squamous cell carcinoma in mice by a mixture of Chinese herbs. Cancer Prev Res 2009;2:634-40.
20. Matsuda H, Namba K, Fukuda S, Tani T, Kubo M. Pharmacological study on Panax ginseng C. A. Meyer. III. Effects of red ginseng on experimental disseminated intravascular coagulation. (2). Effects of ginsenosides on blood coagulative and fibrinolytic systems. Chem Pharm Bull (Tokyo) 1986;34:1153-7. (Pubitemid 16103733)
21. Wang Y, Zhang Z, Yan Y, Lemon WJ, LaRegina M, Morrison C, et al. A chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility. Cancer Res 2004;64:1647-54. (Pubitemid 38428685)
22. McDoniels-Silvers AL, Herzog CR, Tyson FL, Malkinson AM, You M. Inactivation of both Rb and p53 pathways in mouse lung epithelial cell lines. Exp Lung Res 2001;27:297-318. (Pubitemid 32239299)
23. Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007;129:1065-79.
24. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H, et al. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci U S A 1998;95:3537-42.
25. Wang Y, Rouggly L, You M, Lubet R. Animal models of lung cancer characterization and use for chemoprevention research. Prog Mol Biol Transl Sci 2012;105:211-26.
26. Keum YS, Han SS, Chun KS, Park KK, Park JH, Lee SK, et al. Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutat Res 2003;523-524:75-85.
27. Bae EA, Kim EJ, Park JS, Kim HS, Ryu JH, Kim DH. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells. Planta Med 2006;72:627-33.
28. Petersen I. The morphological and molecular diagnosis of lung cancer. Dtsch Arztebl Int 2011;108:525-31.
29. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-93.
30. Lee SJ, Sung JH, Moon CK, Lee BH. Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett 1999;144:39-43.
31. Qi LW, Wang CZ, Yuan CS. American ginseng: potential structure-function relationship in cancer chemoprevention. Biochem Pharmacol 2010;80:947-54.
32. Peng D, Wang H, Qu C, Xie L, Wicks SM, Xie J. Ginsenoside Re: its chemistry, metabolism and pharmacokinetics. Chin Med 2012;7:2.
33. Yu K, Ma Y, Shao Q, Qu H, Cheng Y. Simultaneously determination of five ginsenosides in rabbit plasma using solid-phase extraction and HPLC/MS technique after intravenous administration of 'SHENMAI' injection. J Pharm Biomed Anal 2007;44:532-9.
34. Hwang JW, Oh JH, Yoo HS, Lee YW, Cho CK, Kwon KR, et al. Mountain ginseng extract exhibits anti-lung cancer activity by inhibiting the nuclear translocation of NF-kappaB. Am J Chin Med 2012;40:187-202.
35. Lei J, Li X, Gong XJ, Zheng YN. Isolation, synthesis and structures of cytotoxic ginsenoside derivatives. Molecules 2007;12:2140-50.
36. Chang TL, Ding HY, Kao YW. Role of ginsenoside Rd in inhibiting 26S proteasome activity. J Agric Food Chem 2008;56:12011-5.
37. Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, Azuma I. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull 1994;17:635-9.
38. Hasegawa H, Uchiyama M. Antimetastatic efficacy of orally administered ginsenoside Rb1 in dependence on intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite. Planta Med 1998;64:696-700.